北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 眼科  > 期刊论文
学科主题: 临床医学
题名:
Polyethylene Glycol-Modified Pigment Epithelial-Derived Factor: New Prospects for Treatment of Retinal Neovascularization
作者: Bai, Yu-Jing1; Huang, Lv-Zhen1; Xu, Xiao-Lei2; Du, Wei1; Zhou, Ai-Yi1; Yu, Wen-Zhen1; Li, Xiao-Xin1
刊名: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
发表日期: 2012-07-01
DOI: 10.1124/jpet.112.192575
卷: 342, 期:1, 页:131-139
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Pharmacology & Pharmacy
研究领域[WOS]: Pharmacology & Pharmacy
关键词[WOS]: ENDOTHELIAL GROWTH-FACTOR ; MACULAR DEGENERATION ; GENE-TRANSFER ; DELIVERY ; ANGIOGENESIS ; RETINOPATHY ; PHARMACEUTICALS ; PEGYLATION ; PROTEINS ; DRUGS
英文摘要:

Pathological retinal neovascularization and choroidal neovascularization are major causes of vision loss in a variety of clinical conditions, such as retinopathy of prematurity, age-related macular degeneration, and diabetic retinopathy. Pigment epithelial-derived factor (PEDF) has been found to be the most potent natural, endogenous inhibitor of neovascularization, but its application is restricted because of its instability and short half-life. Polyethylene glycol (PEG) has been used as a drug carrier to slow clearance rate for decades. The present study investigated PEGylated-PEDF for the first time and evaluated its long-term effects on preventing angiogenesis in vitro and in vivo. PEG showed lower cytotoxicity to human umbilical vein endothelial cells (HUVECs). In vitro, PEGylated-PEDF inhibited HUVEC proliferation, migration, tube formation, and vascular endothelium growth factor secretion and induced HUVEC apoptosis in a dose-dependent manner, and it showed a statistically significant difference compared with the PEDF treatment group. In vivo, PEGylated-PEDF had a long-lasting effect in both plasma and retinal concentrations. In an oxygen-induced retinopathy model, one intravitreous injection of PEGylated-PEDF after mouse pups were moved into room air resulted in a significant difference in the inhibition of retinal neovascularization, which decreased the nonperfusion area, compared with the PEDF-treated group. Our present study demonstrated for the first time the long-term inhibitory effects of PEGylated-PEDF on the prevention of neovascularization in vitro and in vivo. These data suggest that PEGylated-PEDF could offer an innovative therapeutic strategy for preventing retinal neovascularization.

语种: 英语
所属项目编号: 2011 CB510200
项目资助者: National Basic Research Program of China&prime ; s 973 Program
WOS记录号: WOS:000305395400014
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/66139
Appears in Collections:北京大学第二临床医学院_眼科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Peoples Hosp, Dept Ophthalmol, Minist Educ,Key Lab Vis Loss & Restorat, Beijing 100044, Peoples R China
2.Dong Xiao Jiang Beijing Sci & Technol Co Ltd, Beijing, Peoples R China

Recommended Citation:
Bai, Yu-Jing,Huang, Lv-Zhen,Xu, Xiao-Lei,et al. Polyethylene Glycol-Modified Pigment Epithelial-Derived Factor: New Prospects for Treatment of Retinal Neovascularization[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,2012,342(1):131-139.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Bai, Yu-Jing]'s Articles
[Huang, Lv-Zhen]'s Articles
[Xu, Xiao-Lei]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Bai, Yu-Jing]‘s Articles
[Huang, Lv-Zhen]‘s Articles
[Xu, Xiao-Lei]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace